Related Experiment Video
Updated: Nov 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy in an extremely preterm infant
Apoorva Aiyengar1, Claire Howarth2, Sujith Pereira2
1Neonatal Unit, Homerton University Hospital NHS Foundation Trust, London, UK a.aiyengar@nhs.net.
Insights
This case study discusses hypertrophic cardiomyopathy (HCM) in an extremely preterm infant. It highlights the challenges in diagnosing the cause of neonatal HCM, considering factors like patent ductus arteriosus (PDA) and steroid exposure.
Area of Science:
- Neonatal Cardiology
- Pediatric Cardiology
- Perinatology
Background:
- Extreme prematurity (24-week gestation) presents unique challenges in neonatal care.
- Neonatal hypertrophic cardiomyopathy (HCM) has diverse etiologies, including genetic, metabolic, endocrine, and medication-induced factors.
- Patent ductus arteriosus (PDA) is common in preterm infants and can lead to cardiac remodeling mimicking HCM.
Abstract:
We present a case of an extreme preterm infant (Baby X) born at 24-week gestation. The echocardiogram showed evidence of hypertrophic cardiomyopathy (HCM) and a patent ductus arteriosus (PDA). There are a number of well-known causes of neonatal HCM including genetic, metabolic and endocrine. PDA is commonly present in preterm infants, and this can contribute to cardiac remodelling and result in cardiac changes mimicking HCM. Furthermore, medications such as steroids can also cause HCM through various mechanisms. A careful consideration of all the different aetiologies for HCM is important for appropriate management of such cases. This report examines the evidence in the literature for the above differential diagnoses and highlights the challenges in diagnosing the underlying cause of HCM in a preterm infant.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

